(Q39644288)

13 September 2017

Androgen regulation of micro-RNAs in prostate cancer (English)

1 reference

13 September 2017

1 reference

Olli-Pekka Kallioniemi

7

1 reference

13 September 2017

Alfonso Urbanucci

4

0 references

Pekka Kohonen

object named as

Pekka J Kohonen

5

0 references

Leena Latonen

object named as

Leena M Latonen

6

0 references

Tapio Visakorpi

object named as

Tapio Visakorpi

9

0 references

author name string

Kati K Waltering

1

1 reference

13 September 2017

Kati P Porkka

2

1 reference

13 September 2017

Sanni E Jalava

3

1 reference

13 September 2017

Guido Jenster

8

1 reference

13 September 2017

13 October 2010

1 reference

13 September 2017

1 reference

13 September 2017

71

1 reference

13 September 2017

6

1 reference

13 September 2017

604-614

1 reference

Androgen receptor outwits prostate cancer drugs.

13 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

MicroRNAs accurately identify cancer tissue origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Impaired microRNA processing enhances cellular transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Functional integration of microRNAs into oncogenic and tumor suppressor pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Widespread deregulation of microRNA expression in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Use of nude mouse xenograft models in prostate cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

The human PC346 xenograft and cell line panel: a model system for prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Evolution of the androgen receptor pathway during progression of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Myc-regulated microRNAs attenuate embryonic stem cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Osteoblasts in prostate cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

The microRNA profile of prostate carcinoma obtained by deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21276

21 January 2018

Identifiers

DOI

10.1002/PROS.21276

1 reference

13 September 2017

1 reference